Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pheochromocytoma × veliparib × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Small Cell Lung Carcinoma 3 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2 Gliosarcoma 2 Glioblastoma 2 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Thrombocythemia, Essential 1 Skin Neoplasms 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Pancreatic Neoplasms 1 Oligodendroglioma 1 Neoplasms 1 Myelodysplastic-Myeloproliferative Diseases 1 Melanoma 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Liver Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Glioma 1 Ependymoma 1

Interventions

3-Iodobenzylguanidine 3 tipifarnib 1 pazopanib 1 lutetium Lu 177 dotatate 1 lenvatinib 1 guadecitabine 1 fostamatinib 1 copper dotatate CU-64 1 cabozantinib 1 atezolizumab 1 Temozolomide 1 Surgical Procedures, Operative 1 Phenoxybenzamine 1 Nivolumab 1 Lutetium-177 1 Lutetium 1 Iodine-131 1 Doxazosin 1 Capecitabine 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡